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Infection of mesangial cells with HIV and SIV: Identification Patients infected with human immunodeficiency virus
of GPR1 as a coreceptor. type 1 (HIV-1) often develop a chronic renal disease
Background. Mesangial cells are an important component known as HIV-1-associated nephropathy (HIVAN) [1–7].of the glomerulus. Dysfunction of mesangial cells is thought
The pathological change commonly observed in the lesionsto be involved in the development of human immunodeficiency
of HIVAN is focal and segmental glomerulosclerosisvirus type 1 (HIV-1)-associated nephropathy (HIVAN). HIVAN
is a structural renal failure frequently observed in patients with (FSGS). However, it is still not clear how HIV-1 is in-
acquired immune deficiency syndrome. However, the suscepti- volved in the development of HIVAN. The principal
bility of mesangial cells to HIV-1 is disputable. More than ten point requiring elucidation is whether HIVAN is causedG protein-coupled receptors, including chemokine receptors,
directly by infection or an interaction of renal cells withhave been shown to act as HIV-1 coreceptors that determine
HIV-1, or indirectly by the response of renal cells tothe susceptibilities of cells to HIV-1 strains with specific cell
tropisms. something such as cytokines released from other nonre-
Methods. We examined the susceptibility of mesangial cells nal cells infected with HIV-1. Successful infection of mes-
to various HIV-1, HIV type 2 (HIV-2) and simian immunode-
angial cells with HIV-1, and, on the contrary, resistanceficiency virus (SIV) strains. Expression of CD4 and HIV/SIV
of renal cells to HIV-1 has been found in studies in whichcoreceptors was examined by Western blotting and polymerase
chain reaction. T cell line (T)-tropic and macrophage (M)-tropic (X4
Results. Mesangial cells were found to be susceptible to and R5) HIV-1 strains were used as inocula. As for the
HIV-1 variant and mutants that infect brain-derived cells, but susceptibility of other renal cells to HIV-1, discrepant
highly resistant to T-tropic (X4), M-tropic (R5) or dual-tropic
results have also been reported [8–10]. It has been shown(X4R5) HIV-1 strains. In addition, mesangial cells were also
that HIV-1-transgenic mice develop progressive renalsusceptible to HIV-2 and SIV strains that infect the brain-derived
cells. Among HIV/SIV coreceptors we tested, the expression lesions that are similar to those observed in human
of GPR1 mRNA was detected in mesangial cells. Expression HIVAN, and that kidneys transplanted into normal mice
of CD4 mRNA and protein was also detected in them. Mesan- from HIV-1-transgenic mice develop FSGS [11, 12].gial cells and GPR1-transduced CD4-positive cells showed sim-
These findings strongly suggest that HIVAN is causedilar susceptibilities to the HIV-1 variant and mutants and HIV-2
by direct infection of renal cells with HIV-1 or by interac-and SIV strains.
Conclusions. CD4 and GPR1 mRNAs were detected in mes- tion of renal cells with gene products of HIV-1.
angial cells. Mesangial cells were susceptible to HIV/SIV strains The early predominant features observed in HIVAN
that use GPR1 as a coreceptor. Our findings suggest that an are mesangial cell hyperplasia and mesangial expansionorphan G protein-coupled receptor, GPR1, is a coreceptor ex-
[4, 6, 13]. In contrast, the primate model of HIV-1-associ-pressed in mesangial cells. It remains to be investigated whether
the interaction of mesangial cells with specific HIV-1 strains ated glomerulopathy showed that damage to mesangial
through GPR1 plays a role in the development of HIVAN. cells occurs in the lesions of monkeys infected with sim-
ian immunodeficiency virus (SIV) [14]. The remnant kid-
ney model of rats as well as the primate model demon-
strated that apoptosis of mesangial cells possibly plays
an important role in the development of FSGS [14, 15].Key words: HIVAN, AIDS, mesangium, CD4, immune deficiency syn-
drome, FSGS, apoptosis. More than ten G protein-coupled receptors (GPCRs),
including chemokine receptors, have been shown to actReceived for publication July 30, 1999
as coreceptors for HIV-1, HIV type 2 (HIV-2), and SIVand in revised form February 7, 2000
Accepted for publication March 10, 2000 [16–28]. Coreceptors mediate the infection processes to-
gether with the first receptor, a CD4 molecule. ThirteenÓ 2000 by the International Society of Nephrology
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GPCRs have been identified as coreceptors that potenti- the growth of mesangium cells well. These brain-derived
cells and mesangial cells stopped growing after 15 to 20ate infection of cell-free HIV/SIV [16–28] when this
study was started. cell passages and showed senescent properties, suggesting
that they originated from normal cells. A human T-cellIn this study we examined the expression of corecep-
tors for HIV-1, HIV-2 or SIV in human mesangial cells line, C8166 [34], was maintained in RPMI 1640 medium
supplemented with 10% (vol/vol) FCS. NP-2 is a humancultured in vitro, and then we examined the susceptibili-
ties to various HIV-1 strains with different cell tropisms glioma cell line. CD4-transduced NP-2 cells (NP-2/CD4),
GPR1-expressing NP-2/CD4 cells (NP-2/CD4/GPR1)[T-tropic (X4), M-tropic (R5), and dual-tropic (X4R5)
strains] and to HIV-1 mutants. That is, we previously and CXCR4-expressing NP-2/CD4 cells (NP-2/CD4/
CXCR4) were made as previously described [21, 30, 35].isolated several HIV-1 variants that infect primary brain-
derived cells (B) such as BT-3 or BT-20/N cells, and a
HIV/SIV strainsCD4-transduced glioma cell line, U87/CD4, as well as T
cell lines (T). These brain-derived cells are highly resis- A T-tropic (X4) HIV-1 strain, IIIb [36], a dual-tropic
(T- and M-tropic) (X4R5) HIV-1 strain GUN1wt [37],tant to X4, R5 and X4R5 viruses [21, 28–30]. In this
article, these variants are referred to as “BT-tropic.” We an M-tropic (R5) HIV-1 strain, BaL [38], and an HIV-1
variant, GUN1v [21, 28–30], were propagated in MOLT-found that mesangial cells are susceptible to BT-tropic
HIV-1 mutants but not to the T-, M- or dual-tropic HIV-1 4#8 [39] cells, phytohemagglutinin (PHA)-stimulated hu-
man peripheral blood lymphocytes (PBL) or U87/CD4strains. Among the coreceptors for HIV/SIV tested, the
expression of GPR1 mRNA was detected in mesangial cells as described previously [21, 28–30, 35]. HIV-1 mutants,
GUN1/A, GUN1/L, GUN1/R, GUN1/S and GUN1/Tcells. We recently reported that GPR1 is a coreceptor
for these variants or mutants [30]. The possible mecha- strains, were constructed by changing the GPGR (glycine-
proline-glycine-arginine) sequence at the V3 tip of thenism for the damage or dysfunction of mesangial cells
by HIV-1 is discussed. Env protein of the GUN1wt strain to GA (alanine) GR,
GL (leucine) GR, GR (arginine) GR, GS (serine) GR
and GT (threonine) GR, respectively, by site-directed
METHODS
mutageneses [30, 40]. GUN1/L and GUN1/R were dual-
Cells tropic (X4R5) strains, while GUN1v, GUN1/A, GUN1/S
and GUN1/T were infectious to brain-derived cells suchPrimary human mesangial cells, HMes and NHMC 2845
(normal human mesangial cell), and the human primary as BT-3, BT-20/N or U87/CD4 cells, which are resistant
to the R5, X4 or R5X4 HIV-1 strains, as well as to C8166skin fibroblasts, TT-5 and SF-TY [31], were maintained
in Dulbecco’s modified Eagle’s minimum essential me- or Molt-4 T cell lines [40]. GUN1v is a variant isolated
from GUN1wt in tissue culture [28]. As for HIV-2dium (DMEM) supplemented with 20% (vol/vol) fetal
calf serum (FCS). The HMes strain was isolated from a strains, ROD/B [41], CBL20, CBL21 and CBL23 [42],
and as for SIV strains, mac251 [43], mndGB-1 [44] andJapanese as previously reported [32]. The NHMC 2845
(NHMC) strain was purchased from BioWhittaker agmTYO-1 [45] were used.
(Walkersville, MD, USA) through TAKARA Shuzo Co.
Virus infection assayLtd. (Kyoto, Japan). The TT-5 strain was derived from
the skin of a five-year-old boy, and SF-TY cells were BT-3, BT-20/N or mesangial cells (HMes and NHMC)
were seeded into 24-well cell culture plates at 3 to 5 3obtained from the Japanese Cancer Research Resources
Bank. BT-3 and BT-20/N cells were fibroblast-like cells 104 cells per well. On the following day, the cells were
washed with heparin-free culture medium and inoculatedisolated from a meningioma and normal human brain
tissue next to a glioblastoma, respectively, as described with one of HIV/SIV strains at 378C for one to several
hours. Amounts of HIV/SIV inoculated were adjustedpreviously [21, 28–30, 33]. BT-3 and BT-20/N cells were
negative for specifically differentiated cell markers in to be 1 3 104 or 1 3 105 cpm by reverse transcriptase (RT)
activities of inocula as previously described [30, 35, 40].the brain, such as Factor VIII-related antigens or glial
fibrillary acidic protein, but were considered to have Then the cells were cultured in a suitable heparin-free
medium. After incubation for 7 to 10 days, the expressionoriginated from blood vessel cells in the brain, as mono-
clonal antibodies against BT-3 cells reacted with blood of HIV/SIV antigens in the infected cells was detected by
indirect immunofluorescence assay (IFA) as describedvessels (unpublished data). These brain-derived BT-3
and BT-20/N cells were maintained in RPMI 1640 me- previously [21, 28–30, 35]. HIV-1-seropositive human
serum or SIVmac-infected monkey serum [30] was used asdium containing 10 mg/mL of endothelial cell growth
supplements (ECGS; Collaborative Biomedical Prod- the first antibody and fluorescent isothiocyanate (FITC)-
conjugated rabbit anti-human immunoglobulins or anti-ucts, Bedford, MA, USA), 10 ng/mL of epidermal growth
factor, and 90 mg/mL of heparin (HEE medium) in gela- simian immunoglobulins (DAKO Co. Ltd., Clostrup,
Denmark) was used as the second antibody in IFA. Ex-tin-coated cell culture dishes. HEE medium supported
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pression of HIV-1 antigens was also confirmed by IFA (U62556); CXCR4, 59-CCAAGGAAGCTGTTGGCT
GAAAAGGTGGTCTA-39 (sense, the 439th to 470th)using a monoclonal antibody (mAb) against p24 [33].
SF-TY, TT-5, U87/CD4, NP-2/CD4, NP-2/CD4/GPR1 and 59-TCCACCTCGCTTTCCTTTGGAGAGGAT
CTT-39 (antisense, the 979th to 1,008th) (X71635); GPR1,and NP-2/CD4/CXCR4 cells were also seeded and in-
fected with HIV/SIV, and they were examined for their 59-ATGGAAGATTTGGAGGAAACATTATTT
GAA-39 (sense, the 1st to 30th) and 59-TTATTGAGCTsusceptibilities to HIV/SIV strains by IFA five to seven
days after infection as described above. Production of GTTTCCAGGAGACACAGATTC-39 (antisense, the
1,038th to 1,050th) (U13666); GPR15, 59-ATGGACCCHIV-1 protein p24 into the culture supernatants of mes-
angial cells infected with GUN1v or GUN1wt strain AGAAGAAACTTCAGTTTATTTG-39 (sense, the 1st
to 30th) and 59-TTAGAGTGACACAGACCTCTTCwas detected by enzyme-linked immunosorbent assay
(ELISA) as described elsewhere [33]. CTCCTCCTGG-39 (antisense, the 1,052nd to 1,083rd)
(U34806); STRL33/Bonzo, 59-AATCTCGACAAGCTC
Monoclonal antibodies ATATGTGGTTACCATG-39 (sense, the 520th to 550th)
and 59-AGATTTCCATTGATGTGAGACCCCAAGA monoclonal antibody against CD4 Nu-T H/I (Nichi-
rei Co. Ltd., Tokyo, Japan) was used to detect expression GTAAG-39 (antisense, the 929th to 960th) (AF007545);
US28, 59-CCGCATTTCCAGAATCGTTGCGGTGTof CD4 in mesangial cells by flow cytometry (FCM) as
described elsewhere [35]. This mAb was also used to CTCAG-39 (sense, the 624th to 654th) and 59-TGTGA
GACGCGACACGCCTCGTCGGACAGCG-39 (anti-examine whether it inhibits infection of mesangial cells
with HIV-1 strains. Cells were treated with mAb for 30 sense, the 1,019th to 1,048th) (L20501); and v28, 59-ATG
GATCAGTTCCCTGAATCAGTGACAGAAAAC-39minutes and then were infected with HIV-1. The culture
supernatants of infected cells were harvested six days (sense, the 1st to 33rd) and 59-TCAGAGAAGGAGC
AATGCATCTCCATCACTCG-39 (antisense, the 1,037thafter infection and examined by ELISA for production
of HIV-1 protein p24 as previously described [33]. to 1,068th) (U20350).
Production of CD4 in mesangial cells was detected by
Expression of CD4 and GPCRs mRNAWestern blotting using Nu-T H/I mAb. mAb bound to
filters was detected by the enhanced chemiluminescence Expression of CD4 and GPCRs mRNA was detected
as previously described [21, 30]. That is, total cellular(ECL) detection kit (GIBCO BRL Co. Ltd., Rockville,
MD, USA) according to the recommended protocol of RNA was isolated from BT-3, BT-20/N, C8166, HMes,
NHMC, U87/CD4 and C8166 cells (1 3 105 cells) usingthe supplier.
an RNA extraction kit (SepaGene; Sanko-Junyaku Co.
Polymerase chain reaction primers for GPCRs Ltd., Tokyo, Japan) following the manufacturer’s proto-
col. Contaminated DNA in RNA preparations was re-Oligonucleotide primers (Nihon Idenshi Kenkyujo,
Co. Ltd., Miyagi, Japan) were used to detect the expres- moved by digestion with 1 U/mL of RNase-free DNase I
(Boerhinger Mannheim Japan Co. Ltd., Tokyo, Japan)sion of GPCR mRNA in BT-3, BT-20/N, C8166, HMes,
NHMC, and U87/CD4 cells by polymerase chain reac- at 378C for two hours. cDNA was made using 2 U/mL
Superscript II reverse transcriptase (GIBCO BRL) intion (PCR) after reverse transcription (RT) of cellular
RNA (RT-PCR) as previously described [21, 30]. The 20 mL of the reaction cocktail containing 2 mg of total
RNA, 0.6 mg oligo-dT (GIBCO BRL), 10 mmol/L Tris-GPCRs examined in this study, and the nucleotide se-
quences, orientations (sense or antisense) and positions HCl (pH 8.3), 50 mmol/L KCl, 1.5 mmol/L MgCl2 2.5
mmol/L of each dNTP, 10 mmol/L dithiothreitol, and 10of the primers in the open reading frame are as follows:
CCR2b, 59-ATGCTGTCCACATCTCGTTCTCGGTT U RNasin (Takara Shuzo Co. Ltd.) at 428C for one hour.
Reverse-transcribed GPCRs or CD4 DNA in the cDNATATCAG-39 (sense, the 1st to 32nd nucleotide sites) and
59-TTATAAACCAGCCGAGACTTCCTGCTCCC preparations was detected by PCR using the specific
primers for each GPCR as described above. PCR wasCAG-39 (antisense, the 1,052nd to 1,083rd) (GenBank
accession number, U03905), CCR3, 59-GCCCGGACTG performed in a reaction mixture (20 mL) containing 10
mmol/L Tris-HCl (pH 8.3), 50 mmol/L KCl, 1.5 mmol/LTCACTTTTGGTGTCATCACCAG-39 (sense, the 433rd
to 464th) and 59-CTTCTCACTAGGAAGGAATGGGA MgCl2, 2.5 mmol/L of each dNTP, 5 U Taq DNA poly-
merase (Takara Shuzo Co. Ltd.) and 60 ng of one of theTGTATCT-39 (antisense, the 982nd to 1,011th) [U49727];
CCR5, 59-GCCAGGACGGTCACCTTTGGGGTGGT PCR primer pairs sense and antisense as follows: 38
cycles of 938C for 30 seconds, 608C for one minute, andGACAA-39 (sense, the 415th to 445th) and 59-AGCCTC
TTGCTGGAAAATAAAACAGCATTT-39 (antisense, 728C for two minutes. The amount of each cell RNA
subjected to RT-PCR was normalized to be equal bythe 964th to 993rd) (U54994); CCR8, 59-GTGAGGAC
GATCAGGATGGGCACAACGCTGTG-39 (sense, the densitometry of DNA bands for glyceraldehyde-3-phos-
phate dehydrogenase (G3PDH) RNA amplified by RT-430th to 461st) and 59-GCTCTCCCTAGGCATTTGT
CTTCCTAGGTA-39 (antisense, the 973rd to 1,002nd) PCR. PCR-amplified DNA fragments were detected
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Fig. 1. Susceptibility of mesangial cells to
HIV-1 strains with different cell tropisms.
Mesangial cells, HMes and NHMC, primary
brain-derived fibroblast-like cells, BT-20/N,
and skin fibroblast strains, TT-5 and SF-TY,
were infected with three HIV-1 strains, IIIb,
GUN1wt and GUN1v, and examined for ex-
pression of HIV-1 antigen by IFA 7 days after
infection. Amounts of HIV-1 inoculated were
adjusted and corresponded to 1 3 105 cpm of
reverse transcriptase (RT) activity as de-
scribed in the Methods section.
through 1% (wt/vol) agarose gel electrophoresis. To esti- (T- and M-tropic) GUN1wt strain (Fig. 1). The mesangial
cells and BT-20/N cells showed similar patterns of sus-mate efficiencies of PCR for CXCR4 and GPR1, plasmid
DNA containing CXCR4 or GPR1 was serially diluted ceptibility to three HIV-1 strains, although there was
marked difference in their susceptibility to GUN1v.and detected by PCR. PCR bands with similar intensities
were detected at the same concentrations of the tem- Human skin fibroblast strains, TT-5 and SF-TY, were
resistant to all of the HIV-1 strains examined (Fig. 1).plates, that is, CXCR4- or GPR1-containing plasmid
DNA (data not shown). The sensitivity of RT-PCR The susceptibility of mesangial cells to the GUN1v
strain was confirmed by detection of HIV-1 p24 in theassays for CXCR4 or GPR1 was determined to be suffi-
cient to allow the detection of a few copies of RNA per culture supernatants of mesangial cells infected with HIV-1
strains (Fig. 2). Mesangial cells, HMes and NHMC, werecell (data not shown).
markedly more susceptible to GUN1v than to GUN1wt.
Infection of mesangial cells and BT-20/N cells with
RESULTS
GUN1v was almost completely inhibited by pretreat-
Infection of mesangial cells with HIV-1 ment of the cells with mAb against CD4 (Fig. 2A).
HMes and NHMC mesangial cells and BT-20/N brain-
Expression of CD4 and GPR1 mRNA in thederived cells were infected with HIV-1 strains with dif-
mesangial cellsferent cell tropisms (Fig. 1). HIV-1 antigens were de-
tected seven days after infection by IFA using human HIV-1 entry into target cells is mediated by CD4 mole-
cules as the first receptor and one of several GPCRs asserum positive for HIV-1 antibodies. The mesangial cells
as well as BT-20/N cells were clearly susceptible to the the coreceptor. We examined the expression of CD4
mRNA in mesangial cells by RT-PCR. As shown inGUN1v variant strain. When the mesangial cells were
inoculated with GUN1v, 20 to 30% cells became HIV-1 Figure 3A, expression of CD4 mRNA was detected in
HMes and NHMC cells as well as in C8166 T cells,antigen-positive. BT-20/N cells were highly susceptible
to GUN1v but not to IIIb or GUN1wt strain as previously suggesting that these mesangial cells would be suscepti-
ble to HIV-1 if some HIV/SIV coreceptors were ex-reported [21, 28–30, 33]. Results of IFA using mAb against
HIV-1 protein p24 were similar to those described above pressed on their cell surface. The skin fibroblast cell
strains TT-5 and SF-TY were negative for CD4 mRNA(data not shown). Morphological changes of mesangial
cells infected with GUN1v were hardly noticed. Unlike (data not shown). The cDNA used in RT-PCR experi-
ments was serially diluted tenfold and the expressionBT-20/N cells, these infected mesangial cells formed few
syncytia (data not shown). In contrast, the mesangial cells level of CD4 mRNA was determined by RT-PCR (Fig.
3B). HMes and NHMC cells were estimated to expressshowed resistance to T-tropic IIIb strain and dual-tropic
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Fig. 2. Detection of HIV-1 protein p24 after
infection. HMes, NHMC, BT-20/N and NP-2/
CD4/GPR1 cells were treated with anti-CD4
mAb and infected with GUN1v (A) or
GUN1wt (B) strain. The cells were passaged
on day 6. Culture supernatants were harvested
on days 2 (h), 4 ( ), 6 ( ) or 14 ( ) after
infection and examined by ELISA for p24.
Symbol (j) is anti-CD4 (a). The culture su-
pernatants of mAb-treated cells were har-
vested on day 6 (A). The GUN1v strain se-
verely damaged NP-2/CD4/GPR1 cells 6 days
after infection (*).
about one thousandfold less CD4 mRNA than C8166 GPCR (Fig. 5). The mRNAs for CCR2b and GPR1 were
regularly detected in HMes and NHMC cells, althoughcells, which are known to be highly sensitive to HIV-1.
Next, CD4 molecules expressed on the surface of HMes CCR2b bands were much fainter than those of GPR1.
Expression of GPR1 RNA was also detected in TT-5or NHMC cells were detected by flow cytometric analy-
ses. However, neither mesangial cell strain gave clearly and SF-TY fibroblasts (data not shown). CCR2b has
been shown to act as a coreceptor for M-tropic HIV-1positive results: only 2 to 7% of the mesangial cells were
estimated to be CD4-positive (data not shown). Expres- strains and several SIV strains [15]. We noticed that
GPR1 is specifically used by HIV-1 variants and severalsion of CD4 in cultured mesangial cells were examined
by Western blotting using the mAb against CD4. About HIV-2 strains that infect brain-derived cells, such as
BT-20/N, BT-3 or U87/CD4 [30, 35, 40, unpublished2 to 5% of CD4 protein detected in human C8166 T
cells was estimated to be present in the mesangial cell data]. These findings suggest that infection of mesangial
cells with HIV-1 is mediated by GPR1 as a coreceptor.lysates (Fig. 4).
We examined the expression of HIV/SIV coreceptors, The relative amounts of GPR1 mRNA expressed in
HMes, NHMC, BT-20/N, BT-3, U87/CD4 and C8166such as CCR2b, CCR3, CCR5, CXCR4, CCR8, STRL33/
Bonzo, US28, v28, GPR1 and GPR15, in the mesangial cells were examined by RT-PCR (Fig. 6). The relative
amount of CXCR4 mRNA expressed in C8166 cells wascells by RT-PCR using specific primer pairs for each
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Fig. 4. Detection of CD4 by Western blotting. Cell lysates of human
origins were electrophoresed, and were examined by mAb against CD4
using the ECL detection system after Western blotting. C8166 T cells
are known to highly express CD4, while K562 erythroleukemia cells
are negative for CD4. Lanes: 1, C8166; 2, K562; 3, BT-20/N; 4, HMes;
5, NHMC.
were tenfold to one hundredfold lower than those of brain-
derived cells such as BT-20/N, BT-3, and U87/CD4 cells.
About one to ten copies of the GPR1 mRNA were esti-
mated to be expressed in a single mesangial cell in average.
Infection of mesangial cells with the single-point
mutants of the V3 tip of HIV-1 Env protein
If infection of mesangial cells with HIV-1 is mediated
through GPR1, mesangial cells and GPR1-transduced
cells should show similar patterns of susceptibility to
various HIV/SIV strains. We examined this possibility.
NP-2/CD4 cells, which were not transduced with any
GPCRs, showed strong resistance to all of the HIV-1,Fig. 3. Detection of CD4 mRNA in mesangial cells. (A) Detection of
CD4 mRNA by RT-PCR. Cellular RNAs extracted from NHMC or HIV-2 or SIV strains examined thus far in our assay
HMes mesangial cells or C8166 T cells were reverse-transcribed, and conditions as described elsewhere [21, 30, 35, 40], al-
CD4 or G3PDH cDNA was detected by PCR (RT-PCR). RT-PCR
though they abundantly expressed CD4 molecules onassay was also done using cellular RNA without reverse transcription,
RT (2). (B) Quantification of CD4 RNA expressed in mesangial cells. their cell surface. NP-2/CD4 cells were transduced with
cDNA made from RNA extracted from HMes, NHMC or C8166 cells GPR1 and CXCR4 and the resultant cells were desig-
was serially tenfold diluted and used for PCR to detect CD4 DNA.
nated NP-2/CD4/GPR1 and NP-2/CD4/CXCR4, respec-Intensities of PCR bands are: 1, clearly detected; 6, faintly detected;
2, not detected. tively. NHMC, NP-2/CD4/GPR1, NP-2/CD4 and NP-2/
CD4/CXCR4 cells were infected with GUN1 mutants.
NP-2/CD4/GPR1 cells were highly susceptible to the vari-
ant type, BT-tropic viruses (GUN1v, GUN1/A, GUN1/T
and GUN1/S), but retained their strong resistance to the
also determined by RT-PCR as a control. C8166 human T-tropic (X4) IIIb strain and dual-tropic (T- and M-tropic)
T cells are highly susceptible to T-tropic HIV-1 strains, (X4R5) strains (GUN1wt, GUN1/L and GUN1/R; Fig. 7)
and this infection is mediated by a major coreceptor, as previously reported [30, 35, 40]. Next, the susceptibili-
CXCR4. As shown in Figure 6, CXCR4 mRNA was ties of the mesangial cells and NP-2/CD4/GPR1 cells were
detected in ten thousandfold diluted cDNA of C8166 compared to these HIV-1 mutants. As shown in Figure 7,
cells. Using the results of the control experiments de- NHMC cells were susceptible to GUN1v, GUN1/A,
scribed in the Methods section we estimated that ten GUN1/S and GUN/T, and thus the patterns of suscepti-
thousand copies of CXCR4 mRNA were expressed in a bility of NHMC cells to the GUN1v variant and GUN1
single C8166 cell. Next, the expression levels of GPR1 mutants were quite similar to those of NP-2/CD4/GPR1
mRNA in various cells were determined as described cells. NP-2/CD4/CXCR4 cells were highly susceptible to
previously [30]. End points of cDNA dilutions that gave all of the HIV-1 strains shown in Figure 7 (data not shown).
positive bands for GPR1 by RT-PCR were as follows:
Susceptibilities of mesangial cells to HIV-2 and SIVsNHMC, 310; HMes, 31; BT-20/N, 3100; BT-3, 3100;
U87/CD4, 31000; and C8166, 31. The levels of GPR1 We noticed that the brain-derived cells as well as NP-2/
CD4/GPR1 cells are susceptible to some HIV-2 and SIVmRNA expressed in mesangial cells, NHMC and HMes,
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Fig. 5. Expression of HIV/SIV coreceptor
RNA detected by RT-PCR. Cellular RNAs
were extracted and examined by RT-PCR us-
ing specific PCR primer pairs for HIV/SIV
coreceptors. G3PDH RNA was detected as a
control. No DNA represents PCR controls
lacking a template for cDNA.
Fig. 6. Quantification of GPR1 and CXCR4
cDNA. RNAs extracted from NHMC and
HMes mesangial cells, BT-20/N, BT-3 and
U87/CD4 brain-derived cells, and C8166 T
cells were reverse transcribed, serially tenfold
diluted and used for PCR. Amounts of cDNA
used were adjusted by results of PCR for
G3PDH.
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Fig. 7. Susceptibility of mesangial cells to
HIV-1 mutants. NHMC cells (RT, 1 3 105
cpm) and NP-2/CD4/GPR1 and NP-2/CD4
cells (RT, 1 3 104 cpm) were infected with
indicated RT amounts of HIV-1. HIV-1 anti-
gen-positive cells were detected by IFA 7 days
(NHMC cells) or 5 days (NP-2/CD4/GPR1
and NP-2/CD4 cells) after infection.
strains in addition to BT-tropic HIV-1 variants [31, 36, infect them in vitro [9]. Karlsson-Parra et al showed that
mesangial cells express CD4 molecules at a detectableunpublished data]. Therefore, we examined the suscepti-
level by FCM [47]. To check these contradictory results,bility of mesangial cells to HIV-2 and SIV. HMes and
we tried to detect expression of CD4 on the surface ofNHMC mesangial cells were inoculated with several
mesangial cells by RT-PCR, FCM and Western blotting.HIV-2 and SIV strains, and they were examined for
We noticed that HMes and NHMC mesangial cellsexpression of HIV-2 or SIV antigens 10 days after infec-
showed, at most, only a marginal level of expression oftion (Fig. 8). Among the HIV-2 strains, CBL23 and
CD4 on their surface: 2 to 7% of the mesangial cellsROD/B but not CBL20 or CBL21 plated onto these
were estimated to be positive under our assay conditionscells. The T-tropic IIIb or M-tropic BaL or SF162 HIV-1
described previously [30, 35, 40]. Results of RT-PCRstrain was not infectious to these cells. As for SIVs,
and Western blotting also showed that the mesangialSIVmac, SIVmnd (Fig. 8) and SIVagm (data not shown)
cells expressed a small amount of CD4 (Figs. 3 and 4).plated onto these mesangial cells, and 5 to 10% of the
One of the reasons for the low susceptibility of the mes-cells became SIV antigen-positive. NP-2/CD4/GPR1 cells
angial cells to the HIV-1 variant and mutants observedwere also susceptible to the CBL23 and ROD/B, but not
in this study as compared with the brain-derived cellsto CBL20 or CBL21, HIV-2 strains and to these three
(Figs. 1, 7, and 8) is thought to be due to the low level ofSIV strains [30, 35, data not shown]. These findings also
CD4 expression in them. Under similar assay conditions,suggest that GPR1 functions as an HIV/SIV coreceptor
these BT-tropic viruses plated much more efficientlyin the mesangial cells.
onto BT-20/N or NP-2/CD4/GPR1 cells than onto the
mesangial cells (Figs. 1, 2, and 7).
DISCUSSION mRNAs for two HIV/SIV coreceptors, GPR1 and
Green, Resnick and Bourgoignie [8] and Kimmel et CCR2b, were expressed in the mesangial cell strains.
al [46] reported that HIV-1 can infect mesangial cells GPR1 mRNA, which had been shown to act as a corecep-
in vitro and that the glomerulus isolated from HIV-1- tor for SIVmac strain [24], was detected in mesangial
infected patients contains the HIV-1 genomic DNA, re- cells by RT-PCR (Figs. 5 and 6). The mRNA of CCR2b,
spectively. However, Alpers, McClure and Burstein re- which is a coreceptor for M-tropic or dual-tropic HIV-1
ported that mesangial cells do not express CD4 mole- [20], was very weakly detected in mesangial cells (Fig. 5).
Expression of the other known HIV/SIV coreceptorscules at a detectable level by FCM and HIV-1 cannot
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Fig. 8. Susceptibility of mesangial cells to
HIV-2 and SIV. HMes ( ) and NHMC ( )
mesangial cells were infected with HIV-2 and
SIV strains as well as HIV-1 strains (RT, 1 3
105 cpm). Viral antigen-positive cells were de-
tected by IFA 10 days after infection.
was not always detected in mesangial cells. These results cells were resistant to GUN1wt, GUN1/L and GUN1/R
strains. Thus, the mesangial cells were susceptible to allsuggest that HIV-1 might infect CD4-positive mesangial
cells using GPR1 or CCR2b as a coreceptor. Immunohis- of the HIV-1 variant and mutants, which have been shown
to use GPR1 as their coreceptor, but not to T-, M- ortochemical study [48] and in situ hybridization study [49]
of renal tissues showed that CCR5 is not expressed in dual-tropic (T- and M-) HIV-1 strains, which cannot use
GPR1 as a coreceptor. The expression of GPR1 mRNAintrinsic renal cells. Our findings on CCR5 expression
in cultured mesangial cells may be consistent with results was also detected in skin fibroblast cells, TT-5 and
SF-TY, although CD4 mRNA was not detected in theseof these reports.
Mesangial cells have been reported to have only slight, cells (data not shown). FSGS is induced in primates
infected with SIVmac [14]. It remains to be determinedor no, susceptibility to either T- or M-tropic HIV-1 strains
[8, 9, 46], and these seemingly contradictory results could whether simian mesangial cells express CD4 and GPR1
and whether simian GPR1 can function as a coreceptorpossibly be explained by our findings that a major core-
ceptor for T-tropic HIV-1 strains, CXCR4, or those for for SIVmac.
We could isolate BT-tropic HIV-1 variants from otherM-tropic HIV-1 strains, CCR5 and CCR3, were not ex-
pressed in mesangial cells, but that GPR1 was expressed strains, GUN4 and GUN7, which had been passaged less
than 10 times in tissue culture. These variants also havein them. NP-2/CD4/GPR1 cells were highly, but not com-
pletely, resistant to T- or dual-tropic HIV-1 strains as serine or threonine at the tip of the V3 region [29]. LaRosa
et al reported nucleotide sequences of a large numbershown in Figures 2 and 7. A small number of cells could
still be infected with T- or dual-tropic HIV-1 strains of HIV-1 present in peripheral blood: a few percent of
HIV-1 strains are expected to have serine, threonine oras reported [30, 35], if a large amount of HIV-1 were
inoculated onto mesangial cells. alanine at the tip of the V3 region [50]. These findings
suggest that HIV-1 strains infectious to mesangial cellsWe have shown that the variant type of HIV-1 strains,
such as GUN1v, GUN1/A, GUN1/S, and GUN1/T, infect may be present in HIV-1-infected persons, although they
may represent a very minor population.the brain-derived cells BT-3, BT-20/N and U87/CD4,
and this infection is mediated by GPR1 [30, 40]. In this If HIV-1 virions or Env proteins bind to mesangial
cells, it is expected that HIV-1 or HIV-1 proteins maystudy, we showed that the mesangial cells HMes and
NHMC as well as the brain-derived cells BT-20/N or damage mesangial cells or affect functions of mesangial
cells. Although mesangial cells have low positivity forBT-3 were susceptible to BT-tropic GUN1v, GUN1/A,
GUN1/S and GUN1/T strains, while both types of the CD4 and GPR1 (Figs. 2 to 4), T-, M- or dual-tropic (T-
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